99. As noted under the agenda item 1, Canada has undertaken a number of IP-related measures in response to COVID-19. This includes our previously-notified amendments to the Patent Act, as outlined in document IP/N/1/CAN/30.
100. As well, with respect to IP office measures, pursuant to the Patent Act, the Trademarks Act, and the Industrial Designs Act, the Commissioner of Patents, the Registrar of Trademarks, and the Minister of Innovation, Science and Industry, respectively, designated all days in the period beginning on 16 March 2020, and ending on 28 August 2020. The result of designating these days was that, if a time period fixed under the Patent Act, Trademarks Act, and Industrial Designs Act in respect of any business before the Canadian Intellectual Property Office (CIPO) for doing anything ended on any of the designated days, that time period was extended to the next day that was not either a designated day or a day that was prescribed under the Patent Rules, the Trademark Regulations, and the Industrial Design Regulations.
101. This meant that all such time limits ending on any of these designated days was extended until 31 August 2020. To ensure continuity of service, CIPO's online services also remain available.
102. CIPO has also launched a pilot programme on accelerated examination of patent applications at no additional cost for inventions related to medical products and processes supporting the response to COVID-19. Applicants can submit a request for accelerated patent examination if: they have a new or existing patent application for an invention that supports the health-related response to COVID-19; and they qualify as a small entity which is a university or a business employing 50 or fewer employees.
103. Finally, we note that a new "COVID-19 related" category of technologies has been added to ExploreIP: Canada's IP Marketplace, which is a searchable database that showcases an inventory of public sector patents held by government, academia or other public sector institutions. ExploreIP's new "COVID-19 related" technology category will allow IP owners to promote technologies that could help in the fight against COVID-19, as well as help interested businesses find and obtain licenses for those technologies. At present, ExploreIP's new technology category includes 58 COVID19applicable technologies from 11 public sector organizations.